Meeting
2024 ASCO Genitourinary Cancers Symposium
Disparities in the incidence of next-generation sequencing (NGS) among patients (pts) with advanced or metastatic prostate cancer (mPC) and urothelial carcinoma (mUC).
Authors
Yeonjung Jo
Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT
Yeonjung Jo , Nishita Tripathi , Soumyajit Roy , Vinay Mathew Thomas , Gliceida Galarza Fortuna , Chadi Hage Chehade , Georges Gebrael , Arshit Narang , Patrick Campbell , Sumati Gupta , Benjamin L. Maughan , Neeraj Agarwal , Umang Swami
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Urothelial Carcinoma
Track
Urothelial Carcinoma
Sub Track
Cancer Disparities
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 542)
DOI
10.1200/JCO.2024.42.4_suppl.542
Abstract #
542
Poster Bd #
D13
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Genomic landscape and therapeutic implications in advanced solid cancers: KOSMOS-II (KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors, KCSG AL-22-09).
First Author: Heejung Chae
Poster
2024 ASCO Annual Meeting
Enhancing prostate cancer diagnosis communication: A multicenter study evaluating the impact of animated videos, CartDiag Prostate study.
First Author: Carole Helissey
Poster
2024 ASCO Genitourinary Cancers Symposium
The 340B Drug Pricing Program and oral specialty drugs for advanced prostate cancer.
First Author: Kassem S Faraj
Poster
2024 ASCO Genitourinary Cancers Symposium
Disparities in prostate cancer mortality and clinical trial availability across vulnerable populations.
First Author: Rishi Sekar